Drop in LDL Cholesterol Greater With Low-, Moderate-Intensity Statins for Seniors

TUESDAY, Aug. 1, 2023 (HealthDay News) -- For older versus younger adults, low- to moderate-intensity statins are associated with a greater reduction in low-density lipoprotein cholesterol (LDL-C), according to a study published online Aug. 1 in the Annals of Internal Medicine.
Giulia Corn, Ph.D., from the Danish Cancer Society Research Center in Copenhagen, and colleagues examined the association between age and LDL-C reduction by statins in a nationwide, register-based cohort study in Denmark from 2008 to 2018. Data were included for 83,958 simvastatin or atorvastatin initiators with LDL-C measurements before and during statin use (12 percent aged 75 years or older).
The researchers found that initiators aged 75 years or older had a higher mean LDL-C percentage reduction than those aged younger than 50 years with low- to moderate-intensity statins (39.0 versus 33.8 percent for simvastatin 20 mg and 44.2 versus 40.2 percent for atorvastatin 20 mg). The adjusted percentage reduction difference was 2.62 points for initiators aged 75 years compared with those aged 50 years. This association was consistent for primary and secondary prevention (2.54 and 2.32 percentage points, respectively), but was small with high-intensity statin initiation (1.36 and −0.58 percentage points for atorvastatin 40 mg and 80 mg, respectively).
"In conclusion, low- to moderate-intensity statin therapy is associated with a greater LDL-C reduction in older than younger persons and may be more appealing as initial treatment in older adults who are at increased risk for adverse events," the authors write.
One author disclosed financial ties to Boehringer Ingelheim.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Blind People Are Better at Sensing Their Heartbeats
WEDNESDAY, March 29, 2023 (HealthDay News) -- People who are blind are better at...
Aspirin Use Not Tied to Clinical Outcomes in Nonobstructive CAD
MONDAY, May 2, 2022 (HealthDay News) -- For individuals with nonobstructive...
Survival Inferior in Black Patients With Acute Myeloid Leukemia
WEDNESDAY, March 23, 2022 (HealthDay News) -- For patients with acute myeloid...
U.S. to Tighten Control of PFAS Chemicals in Drinking Water
TUESDAY, March 14, 2023 (HealthDay News) -- U.S. water utilities will be...